Dr Linda M. Katz
Dr. Linda Katz is the Director for the Office of Cosmetics and Colors (OCAC), in FDA’s Center of Foods and Applied Nutrition (CFSAN); a position that she has held since 2002, and the Interim Chief Medical Officer for CFSAN. Dr. Katz establishes the priorities and missions of OCAC focusing on cosmetic safety, compliance, certification of color additives, and research such as nanotechnology, phototoxicity and percutaneous absorption, and addresses safety and medical concerns for CFSAN regulated products. Dr. Katz is the Agency’s liaison for nanotechnology issues pertaining to food and cosmetics. She is a member of the FDA Nanotechnology Task Force and other FDA nanotechnology working groups, as well as being an active member of CFSAN’s Leadership Board, and other CFSAN and FDA management committees. She has had numerous presentations and publications, including those related to nanotechnology regarding cosmetics and foods issues, and other specific cosmetic topics. Prior to assuming leadership of the Office of Cosmetics and Colors, Dr. Katz held positions in the FDA’s Center for Drug Evaluation and Research (CDER) as Deputy Director for the Division of Over-the-Counter Drug Products, Deputy Director for the Division of Dermatologic and Dental Drug Products, and Team Leader and Acting Director for the Pilot Drug Evaluation Staff.
Dr. Katz received her B.A. in biology from the University of Pennsylvania; a M.P.H. in epidemiology from the University Of Michigan School Of Public Health, and a M.D. from the University of Connecticut. She completed her internship and residency in Internal Medicine, and fellowship in Rheumatology at the George Washington University Medical Center, in Washington, D.C.
